SCHEMBL5887312

SCHEMBL5887312

CCOC(=O)c1ccc(Oc2nc(C)c3ccc(=O)n(-c4ccc(C(N)=O)cc4)c3n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.48
TSHR P16473 5/20 0.46
ALDH1A1 P00352 5/20 0.46
HTT P42858 3/20 0.43
HPGD P15428 3/20 0.43
MAPT P10636 5/20 0.42
NPSR1 Q6W5P4 3/20 0.42
MAPK1 P28482 1/20 0.42
ACHE P22303 2/20 0.41
BCHE P06276 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
GAA P10253 2/20 0.40
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ICAM1 P05362 1/20 0.39
SELE P16581 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5886767 0.88 ALDH1A1 (0.38) TSHRALDH1A1HTTHPGDMAPT
SCHEMBL5887252 0.88 PARP10 (0.45) POLBTSHRALDH1A1HPGDMAPT
SCHEMBL5887052 0.87 PARP10 (0.39) TSHRALDH1A1HPGDMAPK1SMN1; SMN2
SCHEMBL5887098 0.86 PARP10 (0.37) POLBTSHRALDH1A1MAPK1ACHE
SCHEMBL5886936 0.85 MAOB (0.39) ALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL5887577 0.84 ALDH1A1 (0.47) POLBTSHRALDH1A1HTTHPGD
SCHEMBL5887065 0.83 HTT (0.45) POLBTSHRALDH1A1HTTHPGD
SCHEMBL5887259 0.82 PARP10 (0.39) TSHRALDH1A1MAPTMAPK1MEN1
SCHEMBL5886807 0.81 MAPK14 (0.46) POLBALDH1A1HTTHPGDSMN1; SMN2
SCHEMBL5886905 0.80 RORC (0.41) POLBTSHRALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP POLB 77/4885TSHR 3292/4885ALDH1A1 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.